Displaying 1 - 20 of 646
FTC, States Win Protections to Lower Pesticide Prices for American Farmers in Antitrust Case Against Corteva
Syngenta and Corteva, FTC v.
In 2022, the FTC and twelve state partners filed a lawsuit against pesticide manufacturers Syngenta and Corteva. The complaint alleges that each defendant implemented a post-patent loyalty program that paid distributors to forgo buying competing generic products. These generic products contain the same active ingredients as the Syngenta or Corteva versions, at a lower cost. The complaint further alleges that this conduct allowed each defendant to inflate its prices, forcing American farmers to spend millions of dollars more for essential crop protection products. The complaint seeks to bar Syngenta and Corteva from continuing these programs and from entering into any similar arrangements in the future, and to restore competition to affected markets.
CareFirst of Maryland, Inc, et al. v. Amgen, et al.
FTC Secures Major Settlement with Caremark, Resolving Antitrust Case Against Second Drug Middleman
Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin)
The FTC filed a lawsuit against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs.
On February 4, 2026, the Federal Trade Commission secured a landmark settlement with Express Scripts, Inc., and its affiliated entities (collectively “ESI”). The settlement requires ESI to adopt fundamental changes to its business practices that increase transparency, are expected to drive down patients’ out-of-pocket costs for drugs like insulin by up to $7 billion over 10 years, bring millions of dollars in new revenue to community pharmacies each year, and advance the Trump Administration’s key healthcare priorities.
On July 14, 2026, the Federal Trade Commission secured a settlement agreement Caremark Rx LLC and Zinc Health Services LLC (collectively Caremark) .
Caremark has agreed to a settlement agreement that requires the PBM to adopt changes to its business practices to drive down patients’ out-of-pocket costs, increase transparency and ensure community pharmacies are treated fairly.
Statement of Chairman Andrew N. Ferguson Joined by Commissioner Mark R. Meador, In the Matter of Deere & Company
FTC, States Secure Settlement with Deere & Company, Advancing Farmers’ Right to Repair
Deere & Company, FTC v.
On July 8, 2026, the FTC, along with five states, secured an important settlement in an antitrust lawsuit against farm equipment manufacturer Deere & Company that will ensure farmers can enjoy the right to repair their own John Deere tractors and farm equipment.